Mycophenolic Acid ARX (Mycophenolate)
mycophenolate 180 mg enteric tablet, 120 · ORAL · PBS code 9503E
STREAMLINEDWhat it costs
AU$85.79 PBS-determined price per 240 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2024-02-01.
- • Repeats: 5.
- • PBS program: HB.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Prophylaxis of renal allograft rejection
Management
The treatment must be under the supervision and direction of a transplant unit.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
WHO Class III, IV or V lupus nephritis
Management
The condition must be proven by biopsy; AND
Must be treated by a nephrologist or in consultation with a nephrologist.
The name of the consulting nephrologist must be included in the patient medical records.
Sponsor: Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.